Journals / Turkish Journal of Chemistry / 2015 / Cilt: 39 - Sayı: 5

Solid-phase total synthesis of cyclic peptide brachystemin A and its immunomodulating activity

Pages
930–938
Publication Date
2015-12-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The effect of the compound on viability of cells was also evaluated, and it was found to be nontoxic on 3T3 cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Brachystemin A (\textbf{1}) is a biologically active peptide from a Chinese traditional plant \textit{Brachystemma calycinum} D.
📊
Key Findings & Data:The current study describes the complete solid-phase total synthesis of peptide \textbf{1} by using Kenner's sulfonamide safety-catch linker strategy.
💡
Conclusion & Impact:The effect of the compound on viability of cells was also evaluated, and it was found to be nontoxic on 3T3 cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:\textit{Brachystemma calycinum} · cyclic peptide · brachystemin A

Abstract

Brachystemin A (\textbf{1}) is a biologically active peptide from a Chinese traditional plant \textit{Brachystemma calycinum} D. Don. (Caryophyllaceae). The current study describes the complete solid-phase total synthesis of peptide \textbf{1} by using Kenner's sulfonamide safety-catch linker strategy. It was identified by QTOF/MS data and NMR studies. Synthetic peptide \textbf{1} was tested for its immunomodulatory effect on different inflammatory parameters, including production of inflammatory cytokines, interleukin 2 (IL-2), tumor necrosis factor-$\alpha $ (TNF-$\alpha )$, and interleukin-1$\beta $ (IL-1$\beta )$, and generation of nitric oxide (NO$^{.})$. The synthetic peptide \textbf{1} showed a moderate to low level of inhibition on the production of IL-2 (35.2{\%}), TNF-$\alpha $ (19.3{\%}), and IL-1$\beta $(7.5{\%}) at a concentration of 25 $\mu $M. The effect of the compound on viability of cells was also evaluated, and it was found to be nontoxic on 3T3 cells.

Özet

Brachystemin A (\textbf{1}) is a biologically active peptide from a Chinese traditional plant \textit{Brachystemma calycinum} D. Don. (Caryophyllaceae). The current study describes the complete solid-phase total synthesis of peptide \textbf{1} by using Kenner's sulfonamide safety-catch linker strategy. It was identified by QTOF/MS data and NMR studies. Synthetic peptide \textbf{1} was tested for its immunomodulatory effect on different inflammatory parameters, including production of inflammatory cytokines, interleukin 2 (IL-2), tumor necrosis factor-$\alpha $ (TNF-$\alpha )$, and interleukin-1$\beta $ (IL-1$\beta )$, and generation of nitric oxide (NO$^{.})$. The synthetic peptide \textbf{1} showed a moderate to low level of inhibition on the production of IL-2 (35.2{\%}), TNF-$\alpha $ (19.3{\%}), and IL-1$\beta $(7.5{\%}) at a concentration of 25 $\mu $M. The effect of the compound on viability of cells was also evaluated, and it was found to be nontoxic on 3T3 cells.

🔖

Cite This Article

SHAH, Z. A., JABEEN, A., SOOMRO, S., MESAIK, M., CHOUDHARY, M., SHAHEEN, F. (2015). Solid-phase total synthesis of cyclic peptide brachystemin A and its immunomodulating activity. Turkish Journal of Chemistry, Cilt: 39 - Sayı: 5, 930–938. https://ajindex.com/articles/184542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...